Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6ABT
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $25,018
Award facts
- Contract value 100% obligated
- $25,017.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $25,017.54 on July 21, 2025, for the supply of Xtandi 80 mg tablets (60-count units). The award was issued under a firm fixed-price contract type with no set-aside designation, reflecting the company's competitive standing in federal procurement markets. The funding agency is the Defense Logistics Agency's Medical Supply Chain division, and the place of performance is Park Ridge, Illinois, with an ultimate completion date of July 22, 2025.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables firm fixed-price orders for pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The company has established itself as a critical supplier in the federal pharmaceutical supply chain, with a robust portfolio of delivery orders covering prescription medications, biologics, and medical consumables for military health systems. Xtandi, an oncology treatment, represents one of many specialized pharmaceutical products the company routinely supplies to federal healthcare providers through this overarching contract vehicle.
Quick answers
Who was awarded contract SPE2DX25F6ABT?
SPE2DX25F6ABT was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 21, 2025.
How much is contract SPE2DX25F6ABT worth?
The government has obligated $25,018 on SPE2DX25F6ABT.
Is contract SPE2DX25F6ABT an order under another contract?
Yes. SPE2DX25F6ABT is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ABT competed?
The extent of competition for SPE2DX25F6ABT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award